AP2630A - Antiviral composition comprising a sulfated polysaccharide - Google Patents

Antiviral composition comprising a sulfated polysaccharide

Info

Publication number
AP2630A
AP2630A AP2010005170A AP2010005170A AP2630A AP 2630 A AP2630 A AP 2630A AP 2010005170 A AP2010005170 A AP 2010005170A AP 2010005170 A AP2010005170 A AP 2010005170A AP 2630 A AP2630 A AP 2630A
Authority
AP
ARIPO
Prior art keywords
sulfated polysaccharide
antiviral composition
antiviral
sulfated
polysaccharide
Prior art date
Application number
AP2010005170A
Other languages
English (en)
Other versions
AP2010005170A0 (en
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of AP2010005170A0 publication Critical patent/AP2010005170A0/en
Application granted granted Critical
Publication of AP2630A publication Critical patent/AP2630A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AP2010005170A 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide AP2630A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93566807P 2007-08-24 2007-08-24
PCT/EP2008/006910 WO2009027057A1 (fr) 2007-08-24 2008-08-22 Composition antivirale contenant un polysaccharide sulfaté

Publications (2)

Publication Number Publication Date
AP2010005170A0 AP2010005170A0 (en) 2010-02-28
AP2630A true AP2630A (en) 2013-03-28

Family

ID=40198591

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005170A AP2630A (en) 2007-08-24 2008-08-22 Antiviral composition comprising a sulfated polysaccharide

Country Status (27)

Country Link
US (2) US20110059919A1 (fr)
EP (1) EP2178533B1 (fr)
JP (1) JP5647518B2 (fr)
KR (1) KR101571571B1 (fr)
CN (1) CN101784272B (fr)
AP (1) AP2630A (fr)
BR (1) BRPI0815748B8 (fr)
CA (1) CA2696009C (fr)
CY (1) CY1113949T1 (fr)
DK (1) DK2178533T3 (fr)
EA (1) EA018138B1 (fr)
ES (1) ES2406684T3 (fr)
HK (1) HK1144558A1 (fr)
HR (1) HRP20130402T1 (fr)
IL (1) IL203444A (fr)
MA (1) MA31748B1 (fr)
MX (1) MX2010001986A (fr)
MY (1) MY153900A (fr)
NO (1) NO20100097L (fr)
NZ (1) NZ583511A (fr)
PL (1) PL2178533T3 (fr)
PT (1) PT2178533E (fr)
SI (1) SI2178533T1 (fr)
TN (1) TN2010000086A1 (fr)
UA (1) UA102673C2 (fr)
WO (1) WO2009027057A1 (fr)
ZA (1) ZA201000951B (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
SG191697A1 (en) * 2008-07-01 2013-07-31 Marinomed Biotechnologie Gmbh Antiallergic marine biopolymers
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
JP2010248105A (ja) * 2009-04-14 2010-11-04 Bio Plan:Kk ウイルス感染阻害用組成物
MX2012007166A (es) 2009-12-22 2012-07-23 Marinomed Biotechnologie Gmbh Composicion antiviral sinergica y su uso.
JP2011168533A (ja) * 2010-02-18 2011-09-01 Kyosei Seiyaku Kk 抗インフルエンザウイルス剤
WO2011100805A1 (fr) * 2010-02-22 2011-08-25 Marinova Pty Ltd Formulations anti-virales
CN101869110B (zh) * 2010-07-14 2013-03-13 山东圣鹏农药有限公司 一种抗植物病毒病组合物及其应用
WO2012018628A1 (fr) 2010-07-26 2012-02-09 Board Of Regents, The University Of Texas System Procédés d'induction d'une réponse immunitaire par l'intermédiaire d'une administration buccale et/ou sublinguale d'un vaccin
FR2969926B1 (fr) 2011-01-04 2017-03-10 Elicityl Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2012126777A1 (fr) * 2011-03-18 2012-09-27 Marinomed Biotechnologie Gmbh Inhibition de l'activité de la neuraminidase
WO2012138885A1 (fr) * 2011-04-05 2012-10-11 Knocean Sciences, Inc Produits de santé et de bien-être dérivés de macrocystis pyrifera, et méthodes d'utilisation associées
WO2013006795A2 (fr) * 2011-07-07 2013-01-10 Humanitas International Foundation Compositions antivirales et leurs méthodes d'utilisation
CN102764266A (zh) * 2012-07-30 2012-11-07 吉林省辉南长龙生化药业股份有限公司 褐藻多糖硫酸酯在制备预防和治疗慢性阻塞性肺病药物中的用途
CN102988409A (zh) * 2012-11-26 2013-03-27 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗重症肝炎药物中的应用
US9974850B2 (en) 2013-01-25 2018-05-22 Board Of Regents, The University Of Texas System Immunogenic compositions and uses thereof
WO2014113836A1 (fr) * 2013-01-25 2014-07-31 Marinova Pty Ltd Procédés de traitement
CN103301065A (zh) * 2013-06-27 2013-09-18 辽宁亿灵科创生物医药科技有限公司 一种海藻提取物的鼻喷剂及其制备方法
CN105792835B (zh) 2013-12-03 2022-03-25 格罗力马托斯国际有限公司 离子水性组合物
ES2734269T3 (es) 2014-01-22 2019-12-05 Visufarma B V Composición que comprende carragenina tipo iota contra conjuntivitis viral
CN104721221B (zh) * 2015-01-29 2017-08-04 广州暨南生物医药研究开发基地有限公司 琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途
US10660914B2 (en) 2015-07-14 2020-05-26 Marinomed Biotech Ag Stuffy nose deblocking composition having antiviral activity
US10434119B2 (en) * 2016-01-13 2019-10-08 Gargle Water, Inc. Pharyngeal or buccal cavity rinse and process of use thereof
US20170360815A1 (en) * 2016-02-25 2017-12-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
CN106309470B (zh) * 2016-08-30 2021-05-18 闫滨 一种羊栖菜多糖的应用
WO2018144545A1 (fr) 2017-01-31 2018-08-09 Stc.Unm Compositions polypeptidiques riches en arginine et procédés pour les utiliser
JP7261367B2 (ja) * 2018-02-14 2023-04-20 江南化工株式会社 抗ウイルス剤及び抗ウイルス組成物
JP6942350B2 (ja) * 2018-04-26 2021-09-29 江南化工株式会社 抗ウイルス剤及び抗ウイルス用組成物
US20230140869A1 (en) * 2018-07-27 2023-05-11 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
GB2579600B (en) * 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN112137953A (zh) * 2019-06-26 2020-12-29 山东百骏生物科技有限公司 一种用于感冒辅助治疗的液体敷料
US11821111B2 (en) 2019-11-15 2023-11-21 Fred Hutchinson Cancer Center Barcoded influenza viruses and deep mutational scanning libraries including the same
WO2021168173A1 (fr) * 2020-02-20 2021-08-26 Synkine Therapeutics, Inc. Méthodes et compositions pour le traitement d'infections respiratoires virales
AU2021235223A1 (en) * 2020-03-09 2022-09-29 Denis Barritault Composition for the treatment of lesions of the respiratory system
JP2023517239A (ja) 2020-03-12 2023-04-24 デイヴィッド カリス－ヒル、シドニー コロナウイルス感染症および関連するサイトカイン毒性の治療
WO2021191904A1 (fr) * 2020-03-26 2021-09-30 Tree Of Life Pharma Ltd. Méthodes de prévention et de traitement d'une infection virale
WO2021202952A1 (fr) * 2020-04-02 2021-10-07 Linhardt Robert John Compositions incorporant des polysaccharides sulfatés pour l'inhibition du sars-cov-2
NL2025335B1 (en) * 2020-04-10 2021-10-26 Logick Energetics B V Pharmaceutical composition for treatment of corona virus infection
CN111471088B (zh) * 2020-04-21 2021-02-09 北京中科微盾生物科技有限责任公司 一种抑制sars-cov-2感染的多肽、组合物及其用途
CN111686125A (zh) * 2020-06-18 2020-09-22 大连工业大学 卡拉胶在抗新型冠状病毒中的应用
WO2021253643A1 (fr) * 2020-06-18 2021-12-23 大连工业大学 Application de polysaccharides sulfatés contre le nouveau coronavirus
EP3932412A1 (fr) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Composition pharmaceutique antivirale
EP3932411A1 (fr) 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Composition pharmaceutique antivirale
EP3939597A1 (fr) 2020-07-16 2022-01-19 Marinomed Biotech AG Composition pharmaceutique antivirale comprenant du carraghénane
CN114053251A (zh) * 2020-07-29 2022-02-18 苏州融析生物科技有限公司 硫酸化多糖吸入制剂及其在防治新冠病毒相关疾病中的应用
CN112220799A (zh) * 2020-11-02 2021-01-15 江苏泰德医药有限公司 一种抑制病毒的产品及用途
WO2022131282A1 (fr) * 2020-12-15 2022-06-23 正一 中村 Savon, désinfectant, stérilisateur et détergent contenant des algues et un extrait d'algues
WO2022131283A1 (fr) * 2020-12-15 2022-06-23 正一 中村 Aliment et eau potable contenant des algues et leur extrait
EP4079289A1 (fr) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Composition antivirale pour l'administration dans le nez, la bouche ou la gorge
EP4079300A1 (fr) 2021-04-22 2022-10-26 Dutch Renewable Energy B.V. Composition anti-virale pour administration dans le nez, la bouche ou la gorge
GB202109888D0 (en) 2021-07-08 2021-08-25 Pollinner Ltd Nasal spray
EP4130258A1 (fr) 2021-08-02 2023-02-08 Evonik Operations GmbH Micro-organismes affichant des récepteurs leurres viraux
EP4395741A1 (fr) * 2021-08-31 2024-07-10 Polyrizon Ltd. Polymères mucoadhésifs pour administration nasale de médicament
CN114264530B (zh) * 2021-12-30 2023-05-05 重庆市畜牧科学院 一种基于Avicel的病毒蚀斑测定方法及其应用
CN114395538A (zh) * 2022-01-19 2022-04-26 和元生物技术（上海）股份有限公司 一种促进重组病毒载体向细胞外分泌的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
EP0293826A3 (fr) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Application thérapeutique et prophylactique des polysaccharides sulfatés contre le SIDA
CH680265A5 (en) * 1990-06-25 1992-07-31 Madeleine Luescher Mattli Dr Polyanionic cpds. for treatment of myxo- and para-myxo-virus diseases - effective against e.g. influenza, measles, mumps and distemper and use e.g. a sulphonated polysaccharide
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
WO1994015624A1 (fr) * 1993-01-08 1994-07-21 The Population Council Utilisation de polysaccharides sulfates pour prevenir des maladies sexuellement transmissibles
US5658893A (en) 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
CA2262686A1 (fr) 1996-08-12 1998-02-19 Mark E. Fraley Inhibiteurs de la thrombine
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
DE19961307A1 (de) 1999-12-18 2001-07-12 Krewel Meuselbach Gmbh Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut
FR2808687B1 (fr) 2000-04-27 2003-12-05 Goemar Lab Sa Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
CA2414320C (fr) 2000-06-30 2008-04-01 Polydex Pharmaceuticals Limited Sulfate de cellulose et autres polysaccharides sulfates utilises dans la prevention ou le traitement de nombreuses infections, notamment l'infection par le virus du papillome
DE10051955A1 (de) * 2000-10-20 2002-05-02 Wella Ag Haarbehandlungsmittel in Form eines festen und formstabilen Gels
JP2003081841A (ja) 2001-06-26 2003-03-19 Kikkoman Corp 抗アレルギー体質強化剤
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2003093322A2 (fr) * 2002-04-30 2003-11-13 The Population Council, Inc. Formulations ameliorees de polysaccharide sulfate, leurs procedes, preparations et utilisations
CN1744917B (zh) * 2003-02-26 2010-05-05 大塚制药株式会社 经肺给药用缓释性制剂学组合物
WO2005004882A1 (fr) 2003-07-09 2005-01-20 Monash University Polymeres charges antiviraux presentant une resistance a la degradation lysosomale pendant une filtration renale et un passage renal, compositions et methodes d'utilisation correspondantes
US20080004236A1 (en) 2004-02-06 2008-01-03 Comper Wayne D High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
US20080184618A1 (en) * 2005-08-03 2008-08-07 Amcol International Virus-Interacting Layered Phyllosilicates and Methods of Use
US20080241271A1 (en) * 2006-11-08 2008-10-02 Roman Stephen B Foaming anti-adhesion composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180003A (ja) * 1997-09-16 1999-03-23 Yakult Honsha Co Ltd 感染症予防・治療剤
JP2001181188A (ja) * 1999-12-28 2001-07-03 Marine Biotechnol Inst Co Ltd インフルエンザウイルス感染阻害剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MALHOTRA RAJNEESH ET AL: "Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells" MICROBES AND INFECTION, ELSEVIER, PARIS, FR, vol. 5, no. 2, 1 February 2003 (2003-02-01), pages 123-133, XP002443541 ISSN: 1286-4579 *

Also Published As

Publication number Publication date
US20110059919A1 (en) 2011-03-10
PL2178533T3 (pl) 2013-08-30
MA31748B1 (fr) 2010-10-01
MY153900A (en) 2015-04-15
EP2178533B1 (fr) 2013-03-27
UA102673C2 (ru) 2013-08-12
BRPI0815748B8 (pt) 2021-05-25
EA018138B1 (ru) 2013-05-30
CA2696009A1 (fr) 2009-03-05
CN101784272B (zh) 2014-03-12
CA2696009C (fr) 2016-08-02
AP2010005170A0 (en) 2010-02-28
MX2010001986A (es) 2010-03-11
BRPI0815748B1 (pt) 2019-04-24
BRPI0815748A2 (pt) 2015-02-18
DK2178533T3 (da) 2013-05-27
EP2178533A1 (fr) 2010-04-28
JP2011512319A (ja) 2011-04-21
EA201070299A1 (ru) 2010-08-30
CY1113949T1 (el) 2016-07-27
SI2178533T1 (sl) 2013-07-31
AU2008291290A1 (en) 2009-03-05
TN2010000086A1 (en) 2011-09-26
JP5647518B2 (ja) 2014-12-24
KR101571571B1 (ko) 2015-11-24
PT2178533E (pt) 2013-06-03
ES2406684T3 (es) 2013-06-07
ZA201000951B (en) 2011-04-28
WO2009027057A1 (fr) 2009-03-05
US20120237572A1 (en) 2012-09-20
HRP20130402T1 (hr) 2013-06-30
NO20100097L (no) 2010-03-24
NZ583511A (en) 2012-02-24
US10342820B2 (en) 2019-07-09
HK1144558A1 (en) 2011-02-25
CN101784272A (zh) 2010-07-21
IL203444A (en) 2015-05-31
KR20100045468A (ko) 2010-05-03

Similar Documents

Publication Publication Date Title
AP2630A (en) Antiviral composition comprising a sulfated polysaccharide
HK1209648A1 (en) Novel sulfated oligosaccharide derivatives
ZA201003041B (en) Chitosan composition
IL194489A0 (en) Bifunctionalized polysaccharides
EP2239264A4 (fr) Agent antitumoral
GB0709791D0 (en) Antiviral agents
EP1978056A4 (fr) Solution de chitosan hydroxyalkyle
HK1156333A1 (zh) 種硫酸化多聚糖化合物及其製備方法和用途
GB0707000D0 (en) Antiviral agents
EP2081453A4 (fr) Soutien-gorge à balconnets
GB0613952D0 (en) Antiviral agent
GB0805264D0 (en) Antiviral agents
EP2138172A4 (fr) Agent antiviral
GB0803707D0 (en) Antiviral agent
HK1142277A1 (en) Novel antiphlogistic-analgesic agent
HK1171661A1 (en) Agent utilizing helipyrone a helipyrone a
GB2439046B (en) Antiviral product
EP2127675A4 (fr) Agent antiviral
EP2209817A4 (fr) Compositions antivirales
GB0723609D0 (en) Antiviral
GB0721935D0 (en) New Carbohydrate derivatives
GB2452413B (en) A component structure
GB0621782D0 (en) Antiviral agent
GB0724539D0 (en) Polysaccharides
GB0706139D0 (en) A wearable constructional toy